46 related articles for article (PubMed ID: 1088737)
1. Ultra-structural aspects of the liver following the administration of TAO.
Caramia FG
Quad Antibiot; 1975 Jun; ():57-67. PubMed ID: 1088737
[No Abstract] [Full Text] [Related]
2. Effect of low-dose troleandomycin on theophylline clearance: implications for therapeutic drug monitoring.
Kamada AK; Hill MR; Brenner AM; Szefler SJ
Pharmacotherapy; 1992; 12(2):98-102. PubMed ID: 1570234
[TBL] [Abstract][Full Text] [Related]
3. Ultramorphological alterations of club-like protrusions in hepatocytes of triacetyloleandomycin treated rats.
Garaci E; Djaczenko W; Genazzani E
G Batteriol Virol Immunol Microbiol; 1973; 66(7-12):171-5. PubMed ID: 4547343
[No Abstract] [Full Text] [Related]
4. Effects of tracetyloleandomycin on the ultrastructure of the rat liver. II. Late high dose effects.
Garaci E; Djaczenko W; Genazzani E
Ann Sclavo; 1973; 15(3):299-318. PubMed ID: 4544204
[No Abstract] [Full Text] [Related]
5. TAO and theophylline.
Weinberger M
Hosp Pract; 1978 Jul; 13(7):22. PubMed ID: 312756
[No Abstract] [Full Text] [Related]
6. Effects of triacetyloleandomycin on the ultrastructure of the rat liver. I. Low dose and early high dose effects.
Djaczenko W; Garaci E; Genazzani E
Ann Sclavo; 1973; 15(3):281-98. PubMed ID: 4544203
[No Abstract] [Full Text] [Related]
7. Effect of low-dose troleandomycin on glucocorticoid pharmacokinetics and airway hyperresponsiveness in severely asthmatic children.
Ball BD; Hill MR; Brenner M; Sanks R; Szefler SJ
Ann Allergy; 1990 Jul; 65(1):37-45. PubMed ID: 2195921
[TBL] [Abstract][Full Text] [Related]
8. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A.
Quintieri L; Rosato A; Napoli E; Sola F; Geroni C; Floreani M; Zanovello P
Cancer Res; 2000 Jun; 60(12):3232-8. PubMed ID: 10866316
[TBL] [Abstract][Full Text] [Related]
9. [A case of icterus during treatment with triacetyloleoandomycin as sole therapy].
Laburthe-Tolra Y
Sem Hop; 1983 Jun; 59(22):1675-6. PubMed ID: 6308789
[TBL] [Abstract][Full Text] [Related]
10. In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity.
Yu LJ; Drewes P; Gustafsson K; Brain EG; Hecht JE; Waxman DJ
J Pharmacol Exp Ther; 1999 Mar; 288(3):928-37. PubMed ID: 10027828
[TBL] [Abstract][Full Text] [Related]
11. Role of human microsomal and human complementary DNA-expressed cytochromes P4501A2 and P4503A4 in the bioactivation of aflatoxin B1.
Gallagher EP; Wienkers LC; Stapleton PL; Kunze KL; Eaton DL
Cancer Res; 1994 Jan; 54(1):101-8. PubMed ID: 8261428
[TBL] [Abstract][Full Text] [Related]
12. Dose- and time-related effect of troleandomycin on methylprednisolone elimination.
Szefler SJ; Brenner M; Jusko WJ; Spector SL; Flesher KA; Ellis EF
Clin Pharmacol Ther; 1982 Aug; 32(2):166-71. PubMed ID: 6980076
[TBL] [Abstract][Full Text] [Related]
13. The incidence of corticosteroid side effects in chronic steroid-dependent asthmatics on TAO (troleandomycin) and methylprednisolone.
Harris R; German D
Ann Allergy; 1989 Aug; 63(2):110-1. PubMed ID: 2788376
[TBL] [Abstract][Full Text] [Related]
14. [The TAO-methylprednisolone combination in chronic obstructive bronchopneumopathy. Clinical, metabolic and hormonal aspects].
Logroscino CD; Maringelli D; Losito G; Tota N
G Ital Chemioter; 1982; 29(2):133-8. PubMed ID: 6985282
[No Abstract] [Full Text] [Related]
15. [Experiences with a combination therapy of methylprednisolone and troleandomycin in severe bronchial asthma requiring high-dose corticoids].
Menz G; Rothe T; Schmitt M; Schmitz M; Hauser F; Haack D; Virchow C
Pneumologie; 1990 Feb; 44 Suppl 1():238-40. PubMed ID: 2367377
[TBL] [Abstract][Full Text] [Related]
16. Troleandomycin effects on methylprednisolone and methylprednisone interconversion and disposition in the rabbit.
Ebling WF; Rich SA; Szefler SJ; Jusko WJ
Eur J Drug Metab Pharmacokinet; 1987; 12(1):50-7. PubMed ID: 3497038
[TBL] [Abstract][Full Text] [Related]
17. Enzyme kinetics and inhibition of nimodipine metabolism in human liver microsomes.
Liu XQ; Ren YL; Qian ZY; Wang GJ
Acta Pharmacol Sin; 2000 Aug; 21(8):690-4. PubMed ID: 11501176
[TBL] [Abstract][Full Text] [Related]
18. [Antistaphylococcic activity, protective activity in vivo and blood levels in man of triacetyl-oleandomycin and erythromycin].
Colitti G; Liani M; Stella F
Antibiotica; 1970; 8(2):216-25. PubMed ID: 5317332
[No Abstract] [Full Text] [Related]
19. Inhibition of rat liver estrogen 2/4-hydroxylase activity by troleandomycin: comparison with erythromycin and roxithromycin.
Fisher D; Labbe G; Berson A; Tinel M; Loeper J; Larrey D; Pessayre D
J Pharmacol Exp Ther; 1990 Sep; 254(3):1120-7. PubMed ID: 2395109
[TBL] [Abstract][Full Text] [Related]
20. Protection of ethanol-mediated acetaminophen hepatotoxicity by triacetyloleandomycin, a specific inhibitor of CYP3A.
Kostrubsky VE; Szakacs JG; Jeffery EH; Woods SG; Bement WJ; Wrighton SA; Sinclair PR; Sinclair JF
Ann Clin Lab Sci; 1997; 27(1):57-62. PubMed ID: 8997458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
